PharmaCyte Biotech (PMCB) Shares Issued (2014 - 2026)
PharmaCyte Biotech (PMCB) posted quarterly Shares Issued of $5.0 million for Q2 2026, up 324.8% year-over-year from $1.2 million in Q2 2025, and up 67.34% quarter-over-quarter from $3.0 million in Q1 2026.
PharmaCyte Biotech (PMCB) Shares Issued (2014 - 2026) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Shares Issued for 13 consecutive years, with $5.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Shares Issued rose 324.8% year-over-year to $5.0 million; the TTM figure through Apr 2026 stood at $5.0 million (up 324.8% YoY), while the FY2026 annual figure was $5.0 million, up 324.8% from the prior year.
- Shares Issued climbed to $5.0 million in Q2 2026 per PMCB's latest filing, from $3.0 million in the prior quarter.
- Across five years, Shares Issued topped out at $5.0 million in Q2 2026 and bottomed at $37936.0 in Q4 2022.
- Historically, Shares Issued has averaged $1.1 million across 5 years, with a median of $848745.5 in 2024.
- Annual changes were most pronounced in 2022 — Shares Issued sank 99.92% — and 2023, when it jumped 637.56%.
- PharmaCyte Biotech's Shares Issued stood at $37936.0 in 2022, then surged by 637.56% to $279802.0 in 2023, then soared by 230.13% to $923698.0 in 2024, then jumped by 316.27% to $3.8 million in 2025, then grew by 29.26% to $5.0 million in 2026.
- Business Quant data shows PMCB's Shares Issued at $5.0 million in Q2 2026, $3.0 million in Q1 2026, and $3.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - | 4.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 4.97 Mn |
| Apr 30, 2026 | 4.97 Mn |
| Jan 31, 2026 | 2.97 Mn |
| Jan 31, 2026 | 2.97 Mn |
| Oct 31, 2025 | 3.85 Mn |
| Oct 31, 2025 | 3.85 Mn |
| Jul 31, 2025 | 1.60 Mn |
| Jul 31, 2025 | 1.60 Mn |
| Apr 30, 2025 | 1.17 Mn |
| Apr 30, 2025 | 1.17 Mn |
| Jan 31, 2025 | 917,697.00 |
| Jan 31, 2025 | 917,697.00 |
| Oct 31, 2024 | 923,698.00 |
| Oct 31, 2024 | 923,698.00 |
| Jul 31, 2024 | 924,830.00 |
| Jul 31, 2024 | 924,830.00 |
| Apr 30, 2024 | 925,164.00 |
| Apr 30, 2024 | 925,164.00 |
| Jan 31, 2024 | 779,794.00 |
| Jan 31, 2024 | 779,794.00 |